Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06847685 · ClinicalTrials.gov registry record
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
A clinical trial of Endometriosis and Endometrioma, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 140
- Enrollment target
- 3
- Study locations
NCT06847685: Recruiting study of Endometriosis and Endometrioma, sponsored by Johns Hopkins University.
NCT06847685 is a study of Endometriosis and Endometrioma that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 140 participants, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06847685, a study of Endometriosis and Endometrioma, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
The researchers are evaluating mechanisms of uterine fluid absorption during early pregnancy
Primary Outcome
Immunolocalization of ion channel levels ENaCα, SLC5A1 and SLC5A3 in endometrial tissues.
Conditions Studied
Study Locations (3)
Georgia
- University of Georgia - Athens
Maryland
- Johns Hopkins Hospital - Baltimore
New Jersey
- Rutgers University - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2030-02-01 |
What NCT06847685 shows while recruiting
NCT06847685 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower).
The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 0 interventions.
NCT06847685 reports a single indexed study location in Georgia, Maryland, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06847685 about?
NCT06847685 is a clinical study titled "Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)". The researchers are evaluating mechanisms of uterine fluid absorption during early pregnancy
What is the current status of trial NCT06847685?
This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2025-02-01. Estimated completion is 2030-02-01.
What conditions does trial NCT06847685 study?
This clinical trial studies the following conditions: Endometriosis, Endometrioma.
Who is sponsoring clinical trial NCT06847685?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06847685 being conducted?
This trial has 3 study locations across Georgia, Maryland, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06847685's enrollment target sits among peer trials
140 14th of 48 higher than 35 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
The Impact of Yoga on Endometriosis-Related Pain
RECRUITING · NA
-
Endometriosis and Microvascular Dysfunction: Role of Inflammation
RECRUITING · Early Phase 1
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
-
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI